Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Publications

Ivermectin for COVID-19 in adults in the community (PRINCIPLE): An open, randomised, controlled, adaptive platform trial of short- and longer-term outcomes

Hayward G. et al, (2024), Journal of Infection, 88

Randomized controlled trial of molnupiravir SARS-CoV-2 viral and antibody response in at-risk adult outpatients

Standing JF. et al, (2024), Nature communications, 15

Platform adaptive trial of novel antivirals for early treatment of COVID-19 in the community (PANORAMIC): Protocol for a randomised, controlled, open-label, adaptive platform trial of community novel antiviral treatment of COVID-19 in people at increased risk of more severe disease

Gbinigie O. et al, (2023), BMJ Open, 13

Molnupiravir plus usual care versus usual care alone as early treatment for adults with COVID-19 at increased risk of adverse outcomes (PANORAMIC): an open-label, platform-adaptive randomised controlled trial

Butler CC. et al, (2023), The Lancet, 401, 281 - 293

C-reactive protein point-of-care testing and complementary strategies to improve antibiotic stewardship in children with acute respiratory infections in primary care

Staiano A. et al, (2023), Frontiers in Pediatrics, 11

Guidance on C-reactive protein point-of-care testing and complementary strategies to improve antibiotic prescribing for adults with lower respiratory tract infections in primary care

Van Hecke O. et al, (2023), Frontiers in Medicine, 10

Inhaled Budesonide for COVID-19 in People at Higher Risk of Complications in the Community: The UK National Community Randomi

Hobbs R. et al, (2023), Annals of family medicine

Colchicine for COVID-19 in the community (PRINCIPLE): a randomised, controlled, adaptive platform trial

Dorward J. et al, (2022), British Journal of General Practice, 72, E446 - E455

Point-of-care diagnostic technology in paediatric ambulatory care: a qualitative interview study of English clinicians and stakeholders

Raymond ME. et al, (2022), BMJ open, 12

Primary care preparedness for the SARS-CoV-2 pandemic: a survey of NHS GPs

Pilbeam C. et al, (2022), Family Practice, 39, 332 - 339

Author response

Borek A. et al, (2022), The British journal of general practice : the journal of the Royal College of General Practitioners, 72

Role of locum GPs in antibiotic prescribing and stewardship: a mixed-methods study

Borek AJ. et al, (2022), The British journal of general practice : the journal of the Royal College of General Practitioners, 72, e118 - e127

P47 Infographics about antibiotics: making facts accessible

van Hecke O. et al, (2022), JAC-ANTIMICROBIAL RESISTANCE, 4

Exploring primary care clinicians’ views about how best to implement a potential trial around point-of-care tests for common infections in south africa

Epps A. et al, (2021), Diagnostics, 11

Inhaled budesonide for COVID-19 in people at high risk of complications in the community in the UK (PRINCIPLE): a randomised, controlled, open-label, adaptive platform trial

Yu LM. et al, (2021), The Lancet, 398, 843 - 855

Platform Randomised trial of INterventions against COVID-19 in older peoPLE (PRINCIPLE): Protocol for a randomised, controlled, open-label, adaptive platform, trial of community treatment of COVID-19 syndromic illness in people at higher risk

Hayward G. et al, (2021), BMJ Open, 11

Azithromycin for community treatment of suspected COVID-19 in people at increased risk of an adverse clinical course in the UK (PRINCIPLE): a randomised, controlled, open-label, adaptive platform trial

Butler CC. et al, (2021), The Lancet, 397, 1063 - 1074

Association Between Blood Pressure Control and Coronavirus Disease 2019 Outcomes in 45 418 Symptomatic Patients With Hypertension: An Observational Cohort Study

Sheppard JP. et al, (2021), Hypertension, 77, 846 - 855

Colchicine for COVID-19 in adults in the community (PRINCIPLE): a randomised, controlled, adaptive platform trial

PRINCIPLE Trial Collaborative Group None. et al, (2021)

Inhaled budesonide for COVID-19 in people at higher risk of adverse outcomes in the community: interim analyses from the PRINCIPLE trial

PRINCIPLE Collaborative Group None. et al, (2021)

Load More